Financings in Brief: Aurora Biosciences
This article was originally published in The Gray Sheet
Executive Summary
Aurora Biosciences: Files registration statement with the Securities and Exchange Commission for an initial public offering of 3 mil. shares to be priced at $9-11 each. The San Diego-based firm is developing fluorescent assay technologies and an ultra-high throughput screening system. Proceeds from the offering would be used to expand facilities, purchase capital equipment, build up R&D and acquire chemical libraries, as well as to increase working capital and for other general corporate purposes. Alex. Brown & Sons is lead manager for the offering; Hambrecht & Quist and Robertson, Stephens & Company are co-managing...